Dash Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DASH PHARMS, and what generic and branded alternatives to DASH PHARMS drugs are available?
DASH PHARMS has nineteen approved drugs.
Drugs and US Patents for Dash Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dash Pharms | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 091537-004 | Mar 30, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dash Pharms Natco | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 203507-001 | Nov 20, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dash Pharms | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077550-003 | May 14, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dash Pharms | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | SOLUTION;INTRAVENOUS | 206074-001 | Nov 24, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dash Pharms | DISULFIRAM | disulfiram | TABLET;ORAL | 203916-002 | Mar 4, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Dash Pharms | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078083-002 | Apr 12, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.